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Imperfect repeat sequencesHuman α-synuclein is the causative protein of several neurodegenerative diseases, such as Parkinson's
disease (PD) and dementia with Lewy Bodies (DLB). The N-terminal half of α-synuclein contains seven
imperfect repeat sequences. One of the PD/DLB-causing point mutations, E46K, has been reported in the
imperfect repeat sequences of α-synuclein, and is prone to form amyloid ﬁbrils. The presence of seven
imperfect repeats in α-synuclein raises the question of whether or not mutations corresponding to E46K in
the other imperfect KTKE(Q)GV repeats have similar effects on aggregation and ﬁbrillation, as well as their
propensities to form α-helices. To investigate the effect of E(Q)/K mutations in each imperfect repeat
sequence, we substituted the amino acid corresponding to E46K in each of the seven repeated sequences
with a Lys residue. The mutations in the imperfect KTKE(Q)GV repeat sequences of the N-terminal region
were prone to decrease the lag time of ﬁbril formation. In addition, AFM imaging suggested that the Q24K
mutant formed twisted ﬁbrils, while the other mutants formed spherical aggregates and short ﬁbrils. These
observations indicate that the effect of the mutations on the kinetics of ﬁbril formation and morphology of
ﬁbrils varies according to their location.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
α-Synuclein is a natively unfolded protein of unknown function
that is highly expressed in the neurons of the central nervous system.
Since the major ﬁbrillar protein component of Lewy Bodies (LBs) in
both sporadic and familiar PD is α-synuclein, a causative factor for α-
synuclein in PD pathogenesis is strongly supported. This 140-amino-
acid protein consists of three regions: an N-terminal region (1–60),
the non-amyloid component of Alzheimer's disease (NAC) region (61–
95), and a C-terminal region (96–140). The NAC region is recognized
as the core region responsible for the formation of ﬁbrils [1–4], having
cross β-structures in which individual β-strands run perpendicular to
the ﬁber axis [5]. The N-terminal and NAC regions contain seven
imperfect repeats (XKTKEGVXXXX) that include a highly conserved
KTKEGV hexameric motif. Similarities in these imperfect repeats with
those found in apolipoproteins have suggested a possible role in the
association of α-synuclein with lipids through the formation of an α-
helical secondary structure [6,7]. Furthermore, when mixed with lipid
vesicles, including negatively charged phospholipids, 1,1,1,3,3,3-hexa-Tokyo, Koganei, Japan. Tel./fax:
ll rights reserved.ﬂuoro-2-propanol (HFIP) or sodium dodecyl sulfate (SDS), the N-
terminal region of α-synuclein adopts an α-helical conformation
[8,9]. The α-helical form of α-synuclein has been reported not to
ﬁbrillate in vitro [10,11]. These repeat sequences also have the effect of
decreasing the tendency of α-synuclein to form β-sheet structures,
such as ﬁbrils [12]. Previously, we have suggested that KTKEGV motifs
play a signiﬁcant role inmaintaining the natively unfolded status ofα-
synuclein [13].
Rare familial forms of early-onset PD have been linked to the three
independent missense mutations A53T [14], A30P [15] and E46K [16]
in the N-terminal region of α-synuclein. The E46K mutation in the
fourth imperfect repeat sequence increases the ability of ﬁbril
formation and aggregation in vitro [17,18] and in cultured cells [19].
Examinations of PD-linked and synthetic mutants [20] suggest that
the N-terminal region may be important in modulating aggregation
and ﬁbrillation. The presence of seven imperfect repeats in α-
synuclein raises the question of whether or not the mutations in the
corresponding to E46K in the other imperfect KTKE(Q)GV repeats
cause similar effects on aggregation and ﬁbrillation, as well as their
propensities to form α-helices. Therefore, we attempted to introduce
amino acid substitutions at the position corresponding to E46 in each
of the seven imperfect repeats (Fig. 1). We evaluated their propensity
to form ﬁbrils, aggregates and α-helices, as well as their morphology,
Fig. 1. Amino acid substitutions in the imperfect repeat sequences. The primary structure of α-synuclein is divided into three regions: the N-terminal region (upper), the NAC region
(middle) and the C-terminal region (lower). The gray letters represent the amino acids in the characteristic hexamer motif (KTKEGV). The positions of three missense mutations
(Ala53Thr, Ala30Pro, Glu46Lys) involved in the early onset of Parkinsonism-related disease are marked with asterisks (⁎). The positions of the α-synuclein mutations used in this
study are shown under the letters.
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ism (CD) and atomic force microscopy (AFM). Our ﬁndings suggest
that the N-terminal KTKE(Q)GV hexameric repeats are important for
modulating the kinetics of ﬁbrillation and the morphology of ﬁbrils.
We show that the impact of the mutations in the imperfect repeats on
the kinetics of ﬁbril formation and the morphology of ﬁbrils differs
according to their location.
2. Materials and methods
2.1. Chemicals
Thioﬂavin-T (TfT) was purchased from Sigma. 1,1,1,3,3,3-Hexa-
ﬂuoro-2-propanol (HFIP) was purchased from Wako.
2.2. Recombinant technology
The human α-synuclein structural gene was subcloned into pET-
28a(+) expression vector (Novagen). The mutant α-synucleins E13K,
Q24K, E35K, E46K, E61K and E83K were constructed by carrying out
site-directed mutagenesis using the QuikChange® Site-Directed










All mutations were conﬁrmed by DNA sequencing (PerkinElmer
ABI Model 310).
α-Synuclein proteins were puriﬁed and prepared for circular
dichroism (CD)measurements, TfT ﬂuorescence assay, light scattering
assay, and atomic force microscopy (AFM) imaging, as reported
previously [21].
2.3. Circular dichroism measurements
The CD spectra of 0.2 mg/ml α-synuclein at 25 °C were recorded
from 190 to 250 nm in a 0.1-cm cell, at a 1.0-nm bandwidth, a 4-s
response time and a scan speed of 20 nm/min using a J-720
spectropolarimeter (JASCO). Each spectrum was generated from the
average of ﬁve scans. The CD spectrum of 10mMpotassium phosphate
buffer, pH 7.0, was used as the background and subtracted from the
protein spectra. The data are presented as the mean residue molar
ellipticity (deg cm2 dmol−1).2.4. Fibril formation analysis
All protein samples were concentrated to ca. 3.0 mg/ml by using
Amicon Ultra-15 ﬁlters (Millipore) in phosphate buffer saline, pH 7.3,
centrifuged at 150,000 g for 1 h to remove any aggregates, and
adjusted to 2.0 mg/ml. For the thioﬂavin-T (TfT) ﬂuorescence assay,
the protein concentration was 1 mg/ml (70 μM). The α-synuclein
samples were incubated with 25 μM TfT in 96-microwell plates with
ﬂat bottom (Nunc) in a sample volume of 200 μl for each well. Teﬂon
spheres (As-One) were placed into each well of the 96-microwell
plates, which were sealed by tape (Nunc) and incubated at 37 °C with
shaking at 500 rpm. Our preliminary studies in which we removed
aliquots over time for analysis demonstrated that the presence of
25 μM TfT in the reaction mixture does not interference with the
kinetics of amyloid formation (data not shown). Fibril formation was
monitored by TfT ﬂuorescence. The TfT ﬂuorescence was recorded at
486 nmwith excitation at 450 nm using an ARVO MX 1420 multilabel
counter (PerkinElmer). The TfT ﬂuorescence measurements were
plotted as a function of time and ﬁtted to the sigmoidal curve
described using Graphpad Prism 4. A light scattering assay at 330 nm
was carried out to monitor the total aggregation.
2.5. 1,1,1,3,3,3-Hexaﬂuoro-2-propanol titration
HFIP was added to α-synuclein solution in 10 mM potassium
phosphate buffer, pH 7.0, and diluted with the same buffer to obtain
ﬁnal concentrations of 0 to 10% (v/v) HFIP and 0.2 mg/ml α-
synuclein. Samples were analyzed by CD spectroscopy after incuba-
tion at room temperature for 24 h.
2.6. AFM imaging of WT and mutant α-synucleins
For the AFM analysis, 2-μl samples of α-synuclein were incubated
and placed on freshly cleaved mica. After air drying, the mica surfaces
were rinsed three times with Milli-Q water. The samples were then
allowed to air-dry. Tapping mode imaging was performed on a
Nanowizard II™ BioAFM (JPK Instruments, Berlin, Germany) using a
silicon probe (OMCL-AC160TS-C2, Olympus, Tokyo, Japan). The
scanning parameters varied with the individual samples. Some typical
parameters were as follows: set point, 660 mV; driving amplitude,
38 mV; driving frequency, 333.874 kHz.
3. Results
3.1. Aggregation and ﬁbrillation of WT and mutant α-synucleins
The isoelectric points (pI) of α-synuclein increased by the
introduction of Lys in the imperfect repeat sequences in place of Glu
or Gln. The pI values of E13K, E35K, E46K, E61K and E83K (pI=4.81),
as well as that of Q24K (pI=4.75), were slightly greater than that of
Fig. 2. CD spectra of WT and mutant α-synucleins. The CD spectra were determined
after puriﬁcation: WT (black line), E13K (black dashed line), Q24K (black dotted line),
E35K (gray line), E46K (gray dashed line), E61K (gray dotted line) and E83K (gray
dashed and dotted line).
Fig. 4. Changes in α-synuclein light scattering. The OD330 values recorded after the
incubation of the samples were subtracted from those before incubation to determine
the increase in light scattering (ΔOD330). The error bar indicates the SEM (n=3).
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indistinguishable from those of WT, as identical puriﬁcation proce-
dures achieved similar purity levels and yields for all mutants.
To investigate the effect of amino acid substitution on the
secondary structure in solution, far-UV CD analysis was carried out.
Fig. 2 shows that WT and all mutants share a random coil structure,
which is characterized byminima in the vicinity of 198 nm. This shows
that the amino acid substitutions had no impact on the native state of
α-synuclein.
We investigated the effect of amino acid substitutions in the
imperfect repeat sequences on the ﬁbril formation ability using the
ﬂuorescent dye TfT, which interacts speciﬁcally with amyloid ﬁbrils
such that their long axes align in a parallel fashion. The ﬂuorescence
intensity in the vicinity of 482 nm increased when TfT bound to the
amyloid ﬁbrils. The kinetics of ﬁbrillation usually shows a sigmoidal
pattern, from which the lag time can be measured to indicate the
time of nucleation. Fig. 3 shows that the E46K mutant has a shorter
lag time and a higher maximal ﬂuorescence intensity than WT, which
is consistent with previous reports [17,18,22]. The E13K, Q24K and
E35K mutations, located in the N-terminal region, greatly reduced the
lag time compared with that for WT, while E61K and E83K mutations
only slightly decreased the lag time. However, all mutants except
E46K had a much lower maximal ﬂuorescence intensity (b40%)
compared to WT.
As the TfT ﬂuorescence assay is speciﬁc for amyloid ﬁbrils, it cannot
assess other types of aggregates such as oligomers and amorphousFig. 3. Effect of amino acid substitution on the amyloid ﬁbril formation of α-synuclein.
Time course of ﬁbril formation of α-synuclein and its mutants, as determined by TfT
ﬂuorescence assay: WT (black cycle), E13K (black square), Q24K (black triangle), E35K
(black reverse triangle), E46K (white cycle), E61K (white square) and E83K (black
diamond). The error bar indicates the SEM (n=3).aggregates. To compare the total aggregation of WT α-synuclein and
mutant α-synucleins, a light scattering assay was performed. Fig. 4
shows that all mutants were more prone to aggregate than WT.
Although the ΔOD330 values of most of the E/K mutants were more
than twice that of WT, only that of Q24K was approximately 1.5 times
that of WT.
3.2. α-Helix formation of α-synuclein wild type and mutants in the
presence of HFIP
HFIP was used to induce the conversion of α-synucleins to α-
helical structure as model system of membrane surface. Far-UV CD
spectrum of the seven proteins were recorded in 0% to 10% HFIP. Allα-
synucleins assumed spectra characteristic of fully α-helical protein at
10% HFIP (data not shown), with the minima at 208 and 222 nm.
However, in the presence of 2.5% HFIP (Fig. 5), the spectra of E(Q)/K
mutants decreased around 216 nm, representing β-sheet structure,
despite the that of WT was almost same in the absence of HFIP,
showing random structure. These results suggested that E(Q)/K
mutantswere prone to form partially folded intermediates rather than
WT. Furthermore, to examine the transitions, we produced phase
diagrams (Fig. 6) showing the relationship between [θ]λ198 and
[θ]λ222. A linear relationship reﬂects an all-or-none transition
between two different conformations, while nonlinear relation
represents multiple sequential transformations. For WT, E13K, Q24K
(Fig. 6) and the other E(Q)/Kmutants (data not shown), the structuralFig. 5. CD spectra of WT and mutant α-synucleins in the presence of 2.5% HFIP. The CD
spectrawere recorded in the presence of 2.5% HFIP:WT (black line), E13K (black dashed
line), Q24K (black dotted line), E35K (gray line), E46K (gray dashed line), E61K (gray
dotted line) and E83K (gray dashed and dotted line).
Fig. 6. Phase diagrams for the structural changes induced in α-synuclein WT, E13K, and
Q24K by HFIP. The effect of HFIP on the conformation ofα-synucleins: WT (black circles
and black solid lines), E13K (white circles and dashed lines), and Q24K (gray circles and
gray solid lines). The roman numbers, I and II represent the phases of transitions: (I)
from natively unfolded to partially folded intermediates, (II) from partially folded
intermediates to α-helical structure. The arrows represent the breaking points.
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tions: (I) from natively unfolded to partially folded, (II) from a
partially folded intermediates to α-helical conformation. These
observations are also consistent with earlier works [11,13]. However,
the breaking points of E(Q)/Kmutants between two transitions varied
(Fig. 6), which suggest that E(Q)/K mutants can form into the distinct
partially folded intermediates conformations.Fig. 7. AFM images of α-synuclein and its mutants. The samples for AFM imaging were prepa
(G) E83K. Scale bar: 500 nm.3.3. Morphology of α-synuclein ﬁbrils
We investigated the morphology of α-synuclein ﬁbrils and
aggregates by AFM imaging to help explain why the maximal
ﬂuorescence intensity decreased while the light scattering increased
for the E(Q)/K mutants. The results of AFM imaging demonstrate that
the effect of these mutations on the morphology varies according to
their location. WT typically forms amyloid ﬁbrils, having a diameter of
8 nm and a length of 1 μm. Among the E(Q)/K mutants, mature ﬁbrils
could be visualized only in the Q24K and E46K mutants (Fig. 7).
Instead of mature ﬁbrils, the E35K, E61K and E83K mutants formed
short ﬁbrils (6–8 nm in height and less than 0.5 μm in length). The
E13K mutant formed spherical shapes like small oligomers with a
mean height of 8 nm. On the other hand, the Q24K mutant ﬁbrils,
having a diameter of 8 nm and a length of 1 μm, were twisted in form.
4. Discussion
The PD/DLB-causing mutation E46K has been reported on the
fourth imperfect repeat of α-synuclein [16]. The N-terminal KTKEGV
hexameric repeats of α-synuclein can adopt an α-helical secondary
structure in the presence of lipid vesicles [8,9]. These repeat sequences
of α-synuclein may play the same roles, such as conferring a local
propensity for helical conformation and its stabilization. In this study,
we set out to determine whether or not the mutations in the
corresponding position in the other imperfect repeats cause similar
effects on ﬁbrillation and aggregation.
All E(Q)/K mutations in the position which corresponds to E46K
decreased the lag time of ﬁbrillation compared with that of WT. Thered by incubation for 5 days. (A) WT, (B) E13K, (C) Q24K, (D) E35K, (E) E46K, (F) E61K,
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considered to be the folding from a natively unfolded state to a
partially folded intermediate; then, the intermediate becomes
oligomerized, which ﬁnally leads to the formation of ﬁbrils via a
critical nucleus [23]. The decrease in lag time indicates that
substituting the Glu or Gln residue in the imperfect repeat sequences
with a Lys residue readily prompts the conformational change of α-
synuclein to a partially folded intermediate. Monomeric α-synuclein
assumes conformations that are stabilized by long-range interactions
between the C-terminal tail and the N-terminal and NAC region and
act to inhibit oligomerization and aggregation [24]. Recently, C. C.
Rospigliosi et al. have suggested that E46K enhances C-terminal-to-N-
terminal contacts in α-synuclein and any reduction in net negative
charge of the protein such as truncation of C-terminal tail, sequences
changes with disease (e.g. E46K in PD/DLB), and with divergent
evolution (e.g. D121G in mouse α-synuclein), leads to enhance
aggregation [25]. Since all E/K mutations decrease the net negative
charge of the protein, they are expected to enhance aggregation, as
observed in our experiments. In contrast, the aggregation of Q24K
mutation, which does not reduce the net negative charge of the
protein, was lower than that of all E/K mutations. These results were
consistent with their suggestion. The reduction of the TfT ﬂuorescence
intensity in all mutants except E46K could be due to the morphology.
The AFM imaging shows that the ﬁbrils of all mutants were different
from those of WT, and that mature twisted ﬁbrils can be observed in
the Q24K mutant. Interestingly, total aggregation of the Q24K mutant
was lower than that of the other E/K mutants in the light scattering
assay. These data suggest that the aggregation ability of the Q24K
mutant may be lower than that of the other E/Kmutants, even though
Q24K mutant can form amyloid ﬁbrils.
Several studies using hydrogen–deuterium (H/D) exchange and
solid-state nuclear magnetic resonance (ssNMR) spectroscopy and
electron paramagnetic resonance (EPR) spectroscopy [26–28] have
suggested that the cross-β region is located within residues 30–110,
pinpointing residues 35, 61 and 83 in the β-sheet region. Thus, it is
likely that the E35K, E61K and E83K mutants do not form mature
ﬁbrils due to the direct effects of the mutations on the formation of
cross β-structures. Interestingly, residue 46 is not present in the β-
sheet consisting of the cross-β region and located next to the
hydrophobic residues V48 and V49. The E46K mutation may thereby
promote the formation of new β-sheets without disrupting the
endogenous β-sheets. H. Heise et al. have reported that the well-
ordered β-sheet region extends in disease-related A53T-mutant α-
synuclein compared with that of WT [29]. It is interesting to note that
the double mutant K45V/E46V showed a decreased lag time and
formed twisted ﬁbrils [30]. In addition, the E13K and Q24K mutants
formed spherical shapes and twisted ﬁbrils, respectively. Thus, our
data suggest that the N-terminal region may be important in
modulating the morphology, as well as aggregation and ﬁbrillation.
The imperfect repeat sequences of α-synuclein are the regions
that form the α-helical conformation when mixed with lipid
vesicles, including negatively charged phospholipids, HFIP or SDS.
E46K mutation enhanced the ability to bind phospholipids [17].
However, NMR studies revealed that the E46K mutation resulted in
subtle changes in the conformation of the monomeric protein in
the presence of SDS micelles [22]. Our data suggested that all E
(Q)/K mutants formed α-helical conformation in the presence of
10% HFIP, but their propensities of secondary structure, partially
folded intermediates, were different from that of WT. Therefore,
the effect of these mutants on interaction with membrane phospho-
lipids may vary because they have the distinct propensity to form
α-helical conformation.
Our results clearly indicate that E(Q)/K mutants can form the
distinct morphology of aggregates. It is now clear that many proteins
misfold into a variety of aggregates in different conditions such as pH,
temperature, and covalent changes (mutations or chemical modiﬁca-tion) [31]. Recently, it has been reported that structural diversity of
huntigtin-exon1 is involved in apparently different toxicity effects of
the amyloids [32]. Therefore, the toxicity effects of E(Q)/K mutants
might be different due to distinct conformations.
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